ReviewMolecular and clinical oncology2023

New perspectives on metabolic imaging in the management of prostate cancer in 2022: A focus on radiolabeled PSMA‑PET/CT (Review).

Hélène Simon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.